Aim. -This study aimed to explore the associations between abdominal obesity, inflammatory markers and subclinical organ damage in 740 middle-aged patients with type 2 diabetes.
Introduction
Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with type 2 diabetes [1] . Traditional risk factors such as high low-density lipoprotein (LDL) cholesterol, low high-density lipoprotein (HDL) cholesterol, hypertension and smoking do not fully explain the increased cardiovascular risk in patients with type 2 diabetes [1] . Thus, it is of great importance to identify clinically feasible, inexpensive and noninvasive risk-factor assessment tools to predict CVD.
Low-grade inflammation is thought to be involved in the atherosclerotic process, as it has previously been shown that patients with type 2 diabetes present with higher levels of inflammatory markers compared with those without diabetes [2] .
Continuous deposition of oxidized lipoproteins in the vascular wall leads to an inflammatory response from endothelial cells that transmit signals to monocytes to transform into macrophages. However, macrophages can scavenge lipoproteins and become foam cells that lead to fatty streaks in vessel walls. This then initiates the cascade of events that eventually results in atheroma formation in arterial walls [3] . Also, macrophages not only form fatty streaks, but also secrete proinflammatory cytokines [4] . Systemic low-grade inflammation can be measured through circulating levels of the acute-phase reactant C-reactive protein (CRP) and by levels of proinflammatory interleukin (IL)-6.
Development of type 2 diabetes is closely associated with obesity, and abdominal obesity is the best obesity-related predictor of type 2 diabetes [5] . Anthropometric measures are useful in clinical practice as they are both non-invasive and inexpensive. Waist circumference (WC) is currently the most commonly used measurement for abdominal obesity and is highly associated with the risk of developing CVD. However, recent studies have suggested that sagittal abdominal diameter (SAD) may be a better measurement for assessing adverse metabolic profiles [6] [7] [8] .
Intima-media thickness (IMT) of the carotid arteries measured by high-resolution B-mode ultrasound is a widely accepted non-invasive marker of subclinical atherosclerosis [9] . In addition, given its correlation with coronary atherosclerosis and its capacity to predict incident coronary events, carotid IMT has been proposed as a surrogate marker of coronary atherosclerosis [10] . Pulse wave velocity (PWV) measured by tonometry also provides a non-invasive estimate of arterial stiffness, and is an independent predictive risk factor for all-cause mortality and cardiovascular mortality [11] [12] [13] .
The aim of the present study was to compare two different anthropometric measures of abdominal obesity, WC and SAD, in terms of low-grade systemic inflammation and subclinical organ damage as well as atherosclerosis and arterial stiffness in a middle-aged cohort of patients with type 2 diabetes. In addition, the study also explored the association between markers of lowgrade systemic inflammation and subclinical organ damage in such a cohort.
Methods
Baseline data were analyzed from 740 patients who participated in the community-based cohort study Cardiovascular Risk Factors in Patients with Diabetes-A Prospective Study in Primary Care (CARDIPP). CARDIPP was launched in 2005 and completed in 2008 with the aim of identifying markers for CVD to facilitate earlier and individually adjusted interventions in middle-aged patients with type 2 diabetes. CARDIPP comprised data from extended annual follow-ups of patients aged 55-66 years with type 2 diabetes who were consecutively recruited from 25 different primary healthcare centres in the counties of Östergötland and Jönköping in Sweden. Details of the structure and results from CARDIPP have been described and reported elsewhere [14, 15] . The centres were located in different demographic areas and varied in size. However, the model for the treatment and care of type 2 diabetes was similarly organized, and all primary-care centres adhered to the same national guidelines for diabetes care. A total of 761 patients participated in CARDIPP up to 1st November 2008, but due to missing data in 21 cases, the present cohort was ultimately 481 men and 259 women.
Anthropometric measurements
At the primary healthcare centres, nurses specializing in the treatment of diabetes measured blood pressure (BP) after 5 min of seated rest, and the mean of three consecutive readings was used for the study analyses. Height (to the nearest cm) and weight (to the nearest 0.1 kg) were also measured with the patients wearing light indoor clothing. Waist circumference (WC) was measured with the patient standing after normal expiration to the nearest cm at a level midway between the lowest rib and iliac crest. SAD was recorded with the patient lying supine with bent knees, using a standardized sliding-beam caliper at the highest point of the abdomen.
The clinical investigation also included a standardized medical history, with data on diabetes duration and ongoing medication.
Laboratory tests
Blood specimens were drawn in the morning after a 10-h overnight fast. Routine tests such as for HbA 1c , plasma glucose and serum lipids were analyzed according to the usual routine of the primary healthcare centres. HbA 1c was analyzed according to the Swedish Mono-S high-performance liquid chromatography (HPLC) standard, which is approximately 1% below the Diabetes Control and Complications Trial (DCCT) standard. Blood samples were frozen for later analysis by high-sensitivity CRP assay, apolipoprotein (apo)B/apoA-I ratio and cytokines by the Department of Laboratory Medicine at Linköping University Hospital. CRP values > 10 mg/mL were excluded from the analyses as per the current guidelines [16] . Plasma levels of IL-6 and IL-10 were measured with an ultrasensitive cytokine bead assay kit (Invitrogen Corporation, Carlsbad, CA, USA) according to the manufacturer's instructions, and analyzed on a Luminex ® 100 TM system (Luminex Corporation, Austin, TX, USA). The limits of detection were 0.84 and 0.68 pg.mL −1 for IL-6 and IL-10, respectively. The intra-assay coefficient of variation (CV) was 5-12%, while the interassay CV was 17-20%.
Physiological vascular examinations
Carotid ultrasound investigations and PWV and SAD measurements were performed at the Department of Physiology at Linköping University Hospital and at the County Hospital Ryhov in Jönköping. The IMT of the carotid arteries was evaluated using B-mode ultrasonography. A digital ultrasound system (HDI 5000, ATL Ultrasound, Bothell, WA, USA) equipped with a broadband linear transducer (L12-5) was used for scanning the carotid artery in longitudinal section. Electrocardiography (ECG) leads were also in place. For lumen diameter (LD) and IMT determinations during diastole, three consecutive frozen images focused specifically on the lumen-intima echo and media-adventitia echo from the far arterial wall were saved for later analysis. The digital B-mode images were subsequently transferred to a personal computer (PC) with software for offline measurement of LD and IMT (Artery Measurement System II, Image and Data Analysis, Gothenburg, Sweden). Calibration and subsequent measurements were performed by manually tracing a cursor along the leading edge of the intima-lumen echo from the near wall, and the leading edge of the lumen-intima echo and media-adventitia echo from the far wall. A 10-mm section of the common carotid artery in the proximity of the carotid bulb was selected for obtaining the mean LD and farwall IMT. During analysis, the measurement window was hidden from the reader and values saved in a text file. Mean values of IMT and LD from both the right and left carotids were used in all analyses. Aortic PWV was measured by applanation tonometry (SphygmoCor ® System software, model MM3, AtCor Medical, Sydney, Australia) over the carotid and femoral arteries. Aortic pulse wave transit times were measured by ECG-guided readings of femoral artery pulse waves, using the carotid artery pulse wave as the reference site. Surface distances were estimated from the suprasternal notch to the carotid and femoral measurement sites, using a pre-stretched measuring tape to avoid obtaining an additional distance because of a large chest or abdomen. PWV was calculated by dividing the surface distance with the pulse wave transit time according to the formula m × s −1 . Three biomedical scientists performed all vascular measurements. The intraindividual CV for IMT was 10.4% and 8.1% for PWV.
Statistical analyses
SPSS for Windows version 16.0 software (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. Variables with skewed distribution (IL-6, IL-10, CRP) were logtransformed. Pearson correlation coefficients were calculated between the different measurements, using bivariate correlation analysis. Statistical significance was assumed to be at P < 0.05. In the multiple linear-regression analyses with IMT and PWV as dependent variables, an increase of 1 unit for each variable explored was considered a change in IMT and PWV, expressed as the regression coefficient (beta) with 95% confidence intervals (CI). In the stepwise linear regression, criteria for entry were P < 0.05 and, for removal, P > 0.1.
Ethics
The study complied with the Declaration of Helsinki and was approved by the regional ethics review board of Linköping, Sweden.
Results
A total of 213 (29%) patients were treated with diet and exercise only, while the remaining 527 patients were treated with oral glucose-lowering agents (n = 296, 40%), or insulin alone or in combination with oral glucose-lowering agents (n = 231, 31%); 402 (54%) patients were also taking statins. Table 1 presents the characteristics of all 740 patients according to gender, while Table 2 shows the Pearson correlation coefficients for different variables in relation to PWV and IMT. ApoB/apoA-I ratio, IL-6, systolic BP, WC and SAD all correlated significantly with IMT, whereas HbA 1c , diabetes duration, IL-6, IL-10, systolic BP, BMI, WC and SAD correlated significantly with PWV. The Pearson correlation coefficient between IMT and PWV was r = 0.097 (P = 0.01). As shown on Fig. 1a , there were also significant correlations between abdominal obesity, whether measured as SAD or WC, and IMT, PWV, CRP and IL-6. When the analyses shown on Fig. 1a were limited to only patients not treated with statins (n = 402, 54.5%), the significant correlation between WC and IMT was lost, whereas the correlation between SAD and IMT persisted (P = 0.049). In fact, correlations between both WC (r = 0.193, P = 0.001) and SAD (r = 0.253, P < 0.001) with PWV remained statistically significant when analyses were limited to subjects not taking statins. Fig. 1b and 1c show the results of analyses for men and women, respectively. In women, SAD, but not WC, was significantly associated with PWV (P < 0.001), whereas neither SAD nor WC correlated significantly with IMT in women. In men, both SAD and WC correlated significantly with both PWV and IMT (Fig. 1c) .
The relationships shown in Table 2 and Fig. 1 were further explored in multiple linear-regression analyses (Table 3a  and Table 3b ). Table 3a presents multiple linear-regression analyses with IMT as the dependent variable, and age, gender, treatment with statins, systolic BP, CRP, HbA 1c and BMI as independent variables. In this context, both SAD and WC remained significantly associated with IMT. Also, in Table 3b , PWV was entered as the dependent variable, while age, gender, treatment with statins, systolic BP, CRP, HbA 1c and BMI were covariables. In this case, IL-6, IL-10, SAD and WC remained significantly associated with PWV. When adjusted for reported hypertension and treatment with antihypertensive agents as well as glucose-lowering agents, the results (Table 3a and Table 3b ) remained virtually unchanged. Finally, in the stepwise linear regression (not shown here) entering both SAD and WC as independent variables, and PWV as a dependent variable, WC was removed prior to SAD.
Discussion
To the best of our knowledge, this was the first study comparing SAD and WC, and exploring the associations between abdominal obesity, inflammation and markers of subclinical Table 2 Pearson correlation coefficients (r) for intima-media thickness (IMT) and pulse wave velocity (PWV) in 740 middle-aged patients with type 2 diabetes.
IMT PWV organ damage in middle-aged patients with type 2 diabetes. In this study, significant associations were found between abdominal obesity (whether measured as SAD or WC) and subclinical atherosclerosis and arterial stiffness. However, in most analyses, SAD was more robustly associated with IMT and PWV compared with WC. There were also significant associations between abdominal obesity and inflammatory markers, and between inflammatory markers and markers of subclinical organ damage. Interestingly, inflammatory markers were associated with PWV, but not IMT. A recent study in Edinburgh in a similar setting reported that inflammatory markers were not at all correlated with PWV [17] . However, the patients in that study were considerably younger in comparison with our cohort, and age is a major determinant of arterial stiffness. Nevertheless and consistent with our results, CRP has on several occasions been found to be significantly associated with PWV [18, 19] . IMT and PWV are both markers of subclinical organ damage and appear to reflect different pathways in the multifactorial pathogenesis of CVD. As adipose tissue produces the proinflammatory cytokine IL-6 as well as other potentially atherogenic factors, there is a possible link between abdominal obesity and increased inflammatory response in the atherosclerotic process [20] . In the present study, no association was found between conventionally measured lipids (LDL and HDL cholesterol), glycaemic control and CRP with subclinical atherosclerosis in the carotid arteries. However, it did confirm the findings of a previous analysis from a small sample (n = 247) of this study reporting an association between the apoB/apoA-I ratio and IMT [14] . Because classical risk factors such as lipid levels and smoking status are poorly correlated with IMT, there is a need for further information on the clinically feasible determinants of subclinical atherosclerosis.
SAD has previously been shown to be associated with insulin resistance and inflammation the same as or better than traditional anthropometric measurements [6] , and the present study was able to confirm the association between SAD and markers of subclinical inflammation in a population of type 2 diabetes patients. Furthermore, our study found SAD to be associated with increased IMT and PWV in both men and women independent of age, gender, systolic BP, CRP, treatment with statins, HbA 1c and BMI.
It would have been interesting to perform analyses also stratified by gender. However, given the small number of female participants compared with men, this was unlikely to be relevant.
One important factor to consider in clinical practice is the reliability of measurements, and SAD is highly reliable in both lean and obese subjects [21] . In contrast, WC can be measured in various ways and there is no consensus as to which is the best WC measurement protocol [22] . Our present study used the method for measuring WC recommended by the World Health Organization (WHO), taking the measurement midway between the last rib and iliac crest, and not at maximum WC, in contrast to SAD, which is measured at the maximum abdominal height. This might partly explain our finding that SAD was more robustly associated with subclinical atherosclerosis.
The cross-sectional design of our study was a major limitation, making conclusions as to causality impossible. However, it can be concluded that measuring abdominal obesity is a feasible measure not only for obesity, but also for providing information on the degree of low-grade systemic inflammation, atherosclerosis and arterial stiffness in middle-aged patients with type 2 diabetes. In our study, the difference between SAD and WC was subtle, and both measurements would be of value in clinical practice. Our results also indicate that the commonly used risk markers fail to reveal or correlate with low-level subclinical organ damage. If our results are confirmed in further prospective studies, SAD may well prove useful as a more adequate risk-assessment tool compared with WC in clinical practice to identify those patients with type 2 diabetes who are at high cardiovascular risk.
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